|
NASHVILLE, Tenn.--(BUSINESS WIRE)--Jan. 5, 2005--Renal Care Group, Inc. (NYSE: RCI) today announced the acquisition of Cape County Dialysis based in Cape Girardeau, Missouri, which serves more than 250 patients in four outpatient dialysis facilities. The Company did not disclose terms of the transaction.
Gary Brukardt, president and chief executive officer of Renal Care Group, commented, "A key element of our growth strategy is to affiliate with outstanding physician groups through selective acquisitions that meet our return on investment criteria. This acquisition fulfills our clinical and financial objectives, and we look forward to serving the patients who rely on us for life-sustaining care."
Cape Girardeau Nephrology Associates will serve as medical director for the facilities. Dr. Frank Braxton of Cape Girardeau Nephrology Associates commented, "By affiliating with Renal Care Group we have strengthened the long-standing commitment we have to our patients and enhanced our ability to provide high-quality care to those with chronic and acute kidney disease. Together, we will work to improve the quality of life for patients in Southeast Missouri and Northeast Arkansas."
Renal Care Group, Inc. is a specialized dialysis services company that provides care to patients with kidney disease. The Company serves over 30,000 patients at more than 415 outpatient dialysis facilities, in addition to providing acute dialysis services at more than 200 hospitals. Over 8,800 associates provide services across the Company's 33-state network. More information about Renal Care Group, Inc. may be found at www.renalcaregroup.com.
Certain statements in this press release, particularly those of Mr. Brukardt, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements, which are usually preceded by words like expect, plan, intend, believe, will and the like, include statements that necessarily depend on future events. These forward-looking statements reflect management's expectations and are based upon currently available information. These forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of Renal Care Group to differ materially from those expressed in or implied by the forward-looking statements, including risks related to: the integration of acquired companies; compliance with health care and other applicable laws; changes in the Medicare and Medicaid programs; risks related to the drug Epogen (EPO); payment reductions by private insurers, hospitals or managed care organizations; and changes in the health care delivery, financing or reimbursement systems. These and other factors affecting the Company are discussed in more detail in Renal Care Group's reports filed with the Securities and Exchange Commission, including without limitation Renal Care Group's most recent annual report on Form 10-K and quarterly reports on Form 10-Q filed after that annual report. Copies of these filings are available from Renal Care Group upon request.
Contact:
Renal Care Group, Inc.
Terry Proveaux, 615-345-5577
www.renalcaregroup.com
|
Press Releases